Study wrapper · #947

Retatrutide for the treatment of obesity, obstructive sleep apnea and knee osteoarthritis: Rationale and design of the TRIUMPH registrational clinical trials.

Giblin K, Kaplan LM, Somers VK, et al. Diabetes, obesity & metabolism. 2026.

Editor's note

This paper lays out the rationale and novel basket-trial design of the Phase 3 TRIUMPH program for retatrutide, spanning obesity, sleep apnea, and knee osteoarthritis. It reports study structure and endpoints rather than results, which are still to come. A significant registrational program worth tracking, with no efficacy data yet.

Plain-language abstract

A design paper describing the TRIUMPH Phase 3 program, which is evaluating retatrutide for weight management and two obesity-related complications, obstructive sleep apnea and knee osteoarthritis, across more than 5,800 participants.

Mixed